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Isometric Contraction of Dupuytren’s Myofibroblasts
Is Inhibited by Blocking Intercellular Junctions
Jennifer S.N. Verhoekx1,2,4, Liaquat S. Verjee1,4, David Izadi1, James K.K. Chan1, Vicky Nicolaidou1,
Dominique Davidson3, Kim S. Midwood1 and Jagdeep Nanchahal1
Myofibroblasts (MFs) are responsible for both physiological wound and scar contraction. However, it is not
known whether these cells act individually to contract the surrounding matrix or whether they behave in a
coordinated manner. Therefore, we studied intercellular junctions of primary human MFs derived from patients
with Dupuytren’s disease, a fibrotic disorder of the dermis and subdermal tissues of the palm. The cells were
maintained in anchored three-dimensional collagen lattices to closely mimic conditions in vivo. We found that
selective blockade of adherens, mechanosensitive, or gap junctions effectively inhibited contraction of the
collagen matrices and downregulated the MF phenotype. Our data indicate that MFs in part function as a
coordinated cellular syncytium, and disruption of intercellular communication may provide a therapeutic target
in diseases characterized by an overabundance of these contractile cells.
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INTRODUCTION
Dupuytren’s disease is a common fibroproliferative disorder
with a prevalence of over 7% in the United States (Dibenedetti
et al., 2011). The most frequent manifestation is progressive
flexion deformities of the digits of the hand, resulting in
significantly compromised function. The cell responsible for
the contraction of the palmar fascia and hence the digits
in Dupuytren’s disease is the myofibroblast (MF). MFs
characteristically express a-smooth muscle actin (a-SMA),
which is the isoform present in vascular smooth muscle
cells, in addition to the b- and g-cytoplasmic actins that are
traditionally found in fibroblasts (Skalli et al., 1986). MFs in
Dupuytren’s tissue exist in aggregates both at the early phase
of the disease (Rombouts et al., 1989) and also in mature
Dupuytren’s cords, where they represent the vast majority
of the cells in the histological nodules that are found overlying
the finger joints (Verjee et al., 2009). We hypothesized
that the MFs in Dupuytren’s nodules coordinate their activity
via intercellular junctions.
Cells primarily communicate via three distinct means:
adherens junctions, mechanosensitive junctions, and gap
junctions. Adherens junctions are composed of cadherins that
extend through the plasma membrane and mediate calcium-
dependent cell–cell adhesion by homophilic association
of their ectodomains (Yap et al., 1997). The cadherin
receptors associate intracellularly with several structural and
signaling proteins, most notably the catenins, as well as the
actin cytoskeleton (Yap et al., 1997). Cadherins comprise a
large family, of which most members exhibit a tissue-specific
distribution. For example, E-cadherins are exclusively
expressed in the epithelia (Hatta and Takeichi, 1986).
Differentiation of primary rat lung or subcutaneous
fibroblasts to MFs in vitro using transforming growth factor-
b1 (TGF-b1) is accompanied by an increase of OB-cadherin
expression and a decrease of N-cadherin expression, with
concomitant upregulation of a-SMA. In vivo, the development
of MFs in granulating cutaneous wounds was associated
with the upregulation of cadherin expression, and increased
a-SMA expression correlated with markedly higher levels of
OB-cadherin (Hinz et al., 2004). OB-cadherin junctions
exhibit higher adhesion strength than N-cadherin junctions
(Pittet et al., 2008). Inhibition of OB-cadherin, but not of
N-cadherin, with specific peptides reduced the contraction
of MF-populated collagen matrices (Hinz et al., 2004),
suggesting that OB-cadherin-containing intercellular contacts
have an important role in coordinating the contraction of
differentiated MFs.
Mechanosensitive ion channels open when force is trans-
mitted by an adjacent cell via adherens junctions, allowing an
influx of cations such as calcium. They have been described in
a variety of cells ranging from bacteria (Haswell et al., 2011)
to mammalian fibroblasts (Ko et al., 2001). In fibroblasts,
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calcium ion influx through mechanosensitive channels
opened by tension applied via N-cadherins at the adherens
junctions has been shown to recruit intracellular actin
filaments at the intercellular contacts (Ko et al., 2001).
Adjacent cells can also communicate directly via gap
junctions. Gap junctions are composed of six connexin 43
(Cx43) molecules. Hexamers in adjoining cells make direct
contact to allow passage of molecules of up to 1 KDa between
cells via hydrophilic channels. Accumulating evidence
demonstrates that gap junctions are also important in the
generation of MFs from precursor cells. Infusion of gap
junction inhibitors into polyvinyl sponges implanted subcuta-
neously into rats led to reduced collagen deposition and
numbers of a-SMA-positive MFs (Ehrlich and Diez, 2003; Au
and Ehrlich, 2007). TGF-b1, a potent inducer of MF phenotype
(Hinz et al., 2004; Follonier et al., 2008), increased Cx43 and
a-SMA expression in cardiac fibroblasts (Asazuma-Nakamura
et al., 2009). Antisense oligodeoxynucleotides to Cx43
applied to excisional skin wounds in mice led to earlier
appearance followed by the disappearance of MFs, and
overall accelerated healing. This was accompanied by
increased TGF-b1 and collagen-1a expression, and reduced
numbers of neutrophils and macrophages and messenger RNA
(mRNA) for TNF (Mori et al., 2006).
We explored the hypothesis that myofibrobasts from
patients with Dupuytren’s disease act in a coordinated manner
by communicating with each other through adherens,
mechanosensitive, or gap junctions. There is no animal model
for Dupuytren’s disease. In an effort to emulate the in vivo
situation as closely as possible, we used a validated system
whereby we studied cells isolated from nodules excised
from patients with Dupuytren’s disease and cultured up to a
maximum of passage 2 in three-dimensional (3D) collagen
lattices under isometric conditions in a culture force monitor
(CFM) (Verjee et al., 2010). MFs only maintain their
phenotype under stress, and loss of tension is associated
with disassembly of a-SMA within minutes (Hinz et al.,
2001). To assess the relative contribution of each junction
type respectively, we used specific blocking peptides to
N- and OB-cadherins (Hinz et al., 2004), as well as
inhibitory cadherin antibodies, small interfering RNA
(siRNA) blockade of OB- or N-cadherin, carbenoxolone,
which is a saponin that inhibits gap junction communication
by disassembling Cx43-containing plaques (Guan et al., 1996)
and gadolinium, which is an inhibitor of cationic
mechanosensitive channels (Sukharev et al., 1997; Ko et al.,
2001; Follonier et al., 2008; Ermakov et al., 2010). Here, we
show that specific blockade of N- and OB-cadherins,
mechosensitive channels, or intercellular gap junctions leads
to reduced MF contractility in vitro, suggesting that the cells
partly act in concert, effectively as a syncitium.
RESULTS
Dupuytren’s MFs predominantly express OB-cadherin
We examined adherens and gap junctions in MFs and in non-
palmar dermal fibroblasts (human dermal fibroblast (HDF))
from the same patients, and compared the relative expression
of OB- and N-cadherins, and Cx43 in each cell type.
As expected, MFs expressed higher levels of COL1 and
a-SMA mRNA and higher levels of a-SMA protein than HDFs
(Figure 1a). MFs also expressed more OB-cadherin at both
message and protein levels compared with HDFs, but they
expressed less N-cadherin (Figure 1b) and less Cx43
(Figure 1c) compared with HDFs. Within 3D collagen
matrices, adherens junctions, visualized by immunofluorese-
cent staining for b-catenin, were clearly observed between
adjacent MFs (Figure 1d). HDFs in 3D collagen matrices did
not demonstrate the distinctive intracellular organization of
a-SMA in stress fibers that is characteristic of MFs, and
intercellular adherens junctions between HDFs (Figure 1e)
were less well defined than those between MFs. Gap junc-
tions, visualized by immunostaining for Cx43, were more
prominent in HDFs (Figure 1f). Although some of the labeling
was localized to the perinuclear cytoplasm in both HDFs
and MFs, distinctive labeling was visualized at sites of
intercellular contact, particularly between HDFs (white arrows
in Figure 1f).
Blocking OB- or N-cadherins downregulates the MF phenotype
We next examined the contribution of each type of cell
junction to MF and HDF contraction using a number of
different approaches. Inhibition of either OB- or N-cadherins
with specific blocking peptides resulted in a dose-dependent
reduction in the contraction of MFs, whereas control peptides
had no effect (Figure 2a). Neither cadherin-blocking peptide
had any effect on the low baseline contraction of HDFs
(Figure 2b). Neutralizing antibodies for N-cadherin also
resulted in reduced MF contractility in a dose-dependent
manner, compared with isotype controls or antibodies to
the epithelial-specific E-cadherin (Figure 2c). Blockade of
OB-cadherin with peptides resulted in a reduction in a-SMA
and COL1 message and a-SMA protein in MFs but not in
HDFs (Figure 2d). Peptide blockade of N-cadherin also caused
a significant reduction in a-SMA message and a-SMA protein
in MFs but not in HDFs (Figure 2e). Cell viability was not
impaired over 24 h after the addition of any of the peptides or
antibodies. siRNA for OB-cadherin effectively reduced
OB-cadherin mRNA and protein levels in MFs. Silencing of
this cadherin also caused a reduction in a-SMA expression,
and inhibited the isometric contraction of collagen matrices
by MFs (Figure 2f). Similarly, siRNA for N-cadherin effectively
reduced N-cadherin mRNA and protein levels, as well as
a-SMA expression and MF contractility (Figure 2g). siRNA
knockdown of OB-cadherin resulted in the reduction in
OB-cadherin mRNA in HDFs, but had no effect on
OB-cadherin protein or a-SMA expression (Supplementary
Figure S1A online). siRNA knockdown of N-cadherin in HDFs
resulted in a reduction in N-cadherin mRNA and protein, but
had no effect on a-SMA expression (Supplementary Figure S1B
online).
Blocking mechanosensitive junctions downregulates MF activity
Cells also communicate via mechanosensitive junctions that
open as a result of force transmitted through adherens
junctions. Addition of the mechanosensitive channel blocker
gadolinium led to a dose-dependent reduction in contractility
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of MFs (Figure 3a) but not of HDFs (Figure 3b). The reduced
contractility of MFs was accompanied by a reduction of
a-SMA and COL1 message expression, as well as a-SMA
protein (Figure 3c) in MFs but not in HDFs. Cell viability
was unaffected by gadolinium concentrations up to 600mM,
but reduced cell viability was observed at 1,200mM.
Blocking gap junctions selectively inhibits MFs
Finally, we examined the effect of blockade of gap junctions
in MFs and HDFs. Selective blockade of gap junctions by
carbenoxolone resulted in a dose-dependent decrease in
isometric contraction of MFs (Figure 4a) but not of HDFs
(Figure 4b). Carbenoxolone also led to a reduction in the
expression of COL1 mRNA and a-SMA mRNA and protein in
MFs; a reduction in a-SMA mRNA only was observed in HDFs
(Figure 4c). Impaired cell viability was not seen at 24 h after
the addition of carbenoxolone up to a dose of 200mM; higher
concentrations (500–1,000mM) resulted in cell death. siRNA
knockdown of Cx43 in MFs reduced mRNA and protein
expression of Cx43 and a-SMA, as well as a reduction in
contractility of MFs in 3D collagen matrices (Figure 4d).
Silencing of Cx43 in HDFs resulted in reduced expression of
Cx43 and a-SMA mRNA and protein (Supplementary Figure
S1C online). Combined treatment of MFs with neutralizing
antibody to N-cadherin and carbenoxolone did not result in
the reduction of contractility above that seen with carbenox-
olone alone. However, contractility was completely abolished
by the addition of cytochalasin D (Figure 4e).
Inhibitors of intercellular junctions are equally effective before
or after establishment of junctions in vitro
Both MFs and fibroblasts contract 3D collagen lattices.
However, although the latter reach tensional homeostasis at
6 hours, MFs continue to contract (Supplementary Figure S2
online) (Bisson et al., 2004; Verjee et al., 2010). In all the CFM
experiments described above, the inhibitory compounds were
added at the outset of the experiment. It is likely that the
freshly disaggregated MFs need time to re-establish
intercellular junctions and cell–matrix adhesion complexes.
To discriminate between the possibility that blockade of
intercellular communication merely prevents the formation
of intercellular contacts, rather than inhibiting established cell
connections, inhibitors were also added after cells had been
cultured in matrices for 12 hours and cell–cell junctions
established (Figure 1d–f). Comparison of the effect of addition
of inhibitors of adherens, mechanosensitive, or gap junctions
initially or 12 hours later showed no difference in the reduc-
tion of contractility compared with controls (Supplementary
Figure S3A–C online).
DISCUSSION
We hypothesized that MFs in vivo may contract in concert,
with the activity of groups of cells being coordinated via
adherens, mechanosensitive, or gap junctions. Consistent with
previous reports for MFs derived after treatment of fibroblasts
with TGF-b1 (Hinz et al., 2004; Pittet et al., 2008), we
found that MFs from Dupuytren’s tissue expressed more
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OB-cadherin at both message and protein levels than HDFs,
but expressed lower levels of N-cadherin than HDFs.
However, blocking either N- or OB-cadherin was effective
in inhibiting isometric contraction of 3D collagen matrices by
primary MFs from Dupuytren’s nodules. This is in contrast to
previous publications (Hinz et al., 2004; Follonier et al., 2008)
that showed that only an OB-cadherin peptide blocker
inhibited MF contraction, whereas a N-cadherin peptide
blocker only inhibited fibroblast contraction. A possible
explanation of the variance of our findings is the source of
our cells. We used early-passage primary human cells from
patients with Dupuytren’s disease, whereas Follonier et al
(2008) studied subcutaneous rat fibroblasts up to passage
7 and compared them with MFs generated by exposure to
TGF-b1 over 4 days and Hinz et al (2004) studied embryonic
rat subcutaneous and lung fibroblasts and MFs generated by
exposure to TGF-b1 over 5 days. An alternative explanation
may be that intercellular adherence between MFs is crucial
to their function such that blockade of even the relatively
few N-cadherin-containing adherens junctions had a
profound effect. We also found that blockade of N-cadherin
was equally effective using either a peptide inhibitor
or a neutralizing antibody, but we are unable to locate an
effective commercially available neutralizing antibody to
OB-cadherin. These data were confirmed by gene silencing
studies. siRNA inhibition of OB-cadherin or N-cadherin
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resulted in almost complete abolition of their expression at the
mRNA level and, over 24 hours, 30–50% reduction in protein
expression. This was accompanied by a 40–50% reduction in
a-SMA protein and 50% reduction in isometric contraction of
collagen matrices by MFs. In contrast, we found no difference
in contractility following OB- or N-cadherin blockade
in HDFs. Although siRNA inhibition of OB-cadherin in
HDF resulted in reduced OB-cadherin expression,
no reduction in a-SMA expression was observed. This may
be explained by low baseline expression of a-SMA
in HDFs. Similarly, silencing N-cadherin in HDFs
had no significant effect on a-SMA expression despite
relatively more N-cadherin. This may again be owing to
there being far lower baseline a-SMA expression in HDFs
compared with MFs.
HDFs expressed more Cx43 in the resting state and
exhibited prominent immunofluorescent labeling compared
with MFs. The only previous study on gap junctions using cells
derived from Dupuytren’s tissue found that cord-derived cells
showed increased intercellular passage of a dye through their
gap junctions compared with cells derived from matched
nodules (Moyer et al., 2002), which are especially rich in
MFs (Verjee et al., 2009). We have previously shown using
immunohistochemistry thatB83–92% of cells in Dupuytren’s
cords are fibroblasts and do not express a-SMA (Verjee et al.,
2009). We found that carbenoxolone, which disrupts gap
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junctions by dephosphorylation, effectively inhibited isometric
contraction of collagen lattices populated by Dupuytren’s
MFs. Furthermore, specific knockdown of gap junctions
using siRNA directed against Cx43 resulted in a similar
reduction in MF contractility. Follonier et al (2008) found
that the gap junction inhibitors palmitoleic acid or
carbenoxolone did not inhibit the spontaneous Ca2þ
oscillations exhibited by rat MFs, whereas fibroblast Ca2þ
oscillations were effectively desynchronized. Together,
these data demonstrate that gap junctions have a key
role in coordinating MF contraction but not in Ca2þ
oscillations.
TGF-b1 is a potent inducer of the MF phenotype in
quiescent fibroblasts (Hinz et al., 2004; Follonier et al.,
2008), and there is evidence that TGF-b1 and Cx43 are
interlinked. However, the precise relationship between the
two is unclear and varies according to the system studied.
TGF-b1 upregulated Cx43, a-SMA, and matrix components
in primary human aortic smooth muscle cells (Rama et al.,
2006), and it has been shown that Cx43 positively regulated
TGF-b1 activity by competing with Smad 2/3 for binding
to microtubules. In neonatal rat cardiac fibroblasts,
knockdown of the endogenous Cx43 activity with antisense
deoxyneucleotides inhibited a-SMA expression, whereas
overexpression of Cx43 increased a-SMA expression, and
Cx43 acted cooperatively with TGF-b1 to induce a-SMA
expression (Asazuma-Nakamura et al., 2009). The authors
speculated that antifibrotic therapies based on modification of
Cx43 activity may be more appropriate than blocking
TGF-b1 signaling by antagonizing TGF-b1 receptors or
Smads. Although there was a significant increase in TGF-b1
levels in the tissue post myocardial infarct, with no difference
in levels between Cx43 / and control animals, there was
significant downregulation of phosphorylated Smads, which
are downstream signaling mediators in the TGF-b1 pathway,
in Cx43-deficient mice (Zhang et al., 2010). Therefore, it is
possible that in the heart Cx43 does not directly affect TGF-b1
but instead influences downstream Smad signaling. However,
in other systems, the relationship between TGF-b1 and Cx43
appears to be reversed. TGF-b1 inhibited Cx43 expression in
human detrusor smooth muscle cells found in the bladder
(Neuhaus et al., 2009), and human suburothelial MFs showed
reduced Cx43 on the membrane after exposure to exogenous
TGF-b1 (Heinrich et al., 2011). It is possible that in our system
the carbenoxolone had an effect on the TGF-b1 pathway.
Alternatively, carbenoxolone inhibition of MF contractility
may have directly resulted in reduced a-SMA message, as a
loss of MF tension has been shown to disassemble a-SMA
stress fibers in MFs within minutes (Hinz et al., 2001). A direct
link between gap junction inhibition and a-SMA protein
expression and cell contractility is more likely, as we
observed similar effects with specific knockdown of Cx43
with siRNA.
It has been shown in rat MFs that coordination may be
controlled through calcium ion influx via mechanosensitive
channels, as detected by monitoring periodic Ca2þ oscilla-
tions between cells (Follonier et al., 2008). Gadolinium
is a specific mechanosensitive channel blocker that acts by
altering the packing of membrane phospholipids and applying
lateral pressure that squeezes the channels closed (Ermakov
et al., 2010). We found that the inhibition of contraction of the
collagen gel populated by MFs from Dupuytren’s nodules
occurred on exposure to gadolinium in a dose-dependent
manner, and was accompanied by reduced expression of
COL1 and a-SMA message, as well as a-SMA protein levels.
Again, this may reflect the rapid reversal of the MF phenotype
on the release of external stress (Hinz et al., 2001).
We have described the effects of inhibition of each
individual form of intercellular junction in vitro, and the
maximal inhibition in contractility using blocking peptides,
neutralizing antibodies, or siRNA was B50%. In vivo,
the various junctions are likely to function concurrently. For
example, it has been shown that there is an intimate associa-
tion between gap junctions and adherens junctions, although
the latter are classically considered to transmit mechanical
force between cells. In 3T3 cells, intracellular coassembly of
Cx43 and N-cadherin is required for gap and adherens
junction formation, a process that probably underlies the
close association between gap and adherens junction forma-
tion (Wei et al., 2005). Furthermore, mechanosensitive
channels are dependent on force transmitted by adherens
junctions. Inhibition of each type of intercellular junction
individually failed to abolish tension in the collagen
matrices completely. Of all the blockers of intercellular
junctions, carbenoxolone had the greatest inhibitory effect
on cell contraction in the CFM. Combined inhibition of gap
junctions and adherens junctions did not result in any further
reduction over that achieved by gap junction blockade
alone. However, the addition of cytochalasin D, an actin-
depolymerizing agent (Cooper, 1987), resulted in complete
abolition of contractility. These data confirm that MF
contraction is wholly dependent on an intact cellular
cytoskeleton, and suggest that in the absence of effective
intercellular communication residual tension exerted
by individual cells on the matrix also contributes to MF
contraction.
Taken together, our data suggest that MFs act in concert to
contract 3D collagen matrices, and our in vitro findings
indicate that this coordinated activity is responsible
for B50% of the contractile effect. The remainder is likely
to be owing to the action of the individual MFs on the
surrounding matrix. It has been suggested that the force
generated by cell contraction is transmitted to the extracellular
matrix, which is remodeled to a shortened position,
a mechanism termed ‘lock-step’ (Follonier et al., 2008).
Our data show that inhibitors that disrupt adherens,
mechanosensitive, or gap junctions can each result
in a significant decrease in MF activity, and hence
contraction. This may offer a therapeutic approach to
downregulate MF activity in cutaneous and musculoskeletal
fibrotic disorders.
MATERIALS AND METHODS
Patient samples
Tissue samples were obtained after institutional approval of
experiments, informed written consent, and adherence to Helsinki
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Guidelines (REC 07/H0706/81). Dupuytren’s nodular tissue and
matched full-thickness skin (harvested from the groin or medial
aspect of arm) were obtained from patients with Dupuytren’s disease
undergoing dermofasciectomy.
Cell culture
HDFs were isolated from non-palmar skin, and Dupuytren’s MFs
were isolated from a-SMA-rich nodules (Verjee et al., 2010). Tissue
samples were dissected into small pieces and digested in DMEM
(Lonza, Cambridge, UK) with 1% penicillin–streptomycin (PAA) and
5% fetal bovine serum (FBS) (Gibco, Paisley, UK) with type I
collagenase (Worthington Biochemical Corporation, Reading, UK)þ
DNase I (Roche Diagnostics, West Sussex, UK) for up to 2 hours at
37 1C. Cells were cultured in DMEM with 10% FBS and 1%
penicillin–streptomycin at 37 1C in a humidified incubator with 5%
CO2. Cells up to passage 2 were used for experiments.
Culture force monitor
Measurement of the isometric contractile forces generated by cells
within 3D collagen matrices was performed as previously described
(Verjee et al., 2010). Briefly, 2 106 cells were seeded in 2.5 ml of
type I collagen gel (FirstLink, Birmingham, UK), and the resulting 3D
matrices were suspended between two flotation bars and held
stationary at one end, whereas the other was attached to a force
transducer. Fibroblast-populated collagen lattice–generated tensional
forces were continuously measured for 24 hours and data logged
every minute (dynes: 1 10 5 N). Cell-populated matrices were
cultured in DMEM with 10% FBS and 1% penicillin–streptomycin at
37 1C in a humidified incubator for 24 hours with 5% CO2 and treated
with either N- or OB-cadherin peptide blockers (Adherex, Durham,
NC) and respective control peptide blockers, anti-N-cadherin anti-
body (Sigma, Gillingham, UK), anti-OB-cadherin antibody (Santa
Cruz, Mubio, Maastricht, The Netherlands), anti-E-cadherin antibody
(Invitrogen, Paisley, UK), IgG isotype control, gadolinium, or carbe-
noxolone (Sigma). Compounds were added to CFM culture constructs
at the start of the experiment, except as in Supplementary Figure S3
online, where compounds were added either at the start or 12 hours
later. Cytochalasin D (Sigma) was added at a saturating dose of
20mg ml 1 cytochalasin D (Sigma) to fibroblast-populated collagen
matrices (Townley et al., 2009). Experiments using each patient
sample were performed in triplicate. Data are shown as the
mean±SEM from nX3 patients.
Quantitative reverse transcription PCR
Cells were cultured in monolayer and treated with either N- or
OB-cadherin peptide blockers, gadolinium, or carbenoxolone for
24 hours, and total RNA was extracted from each sample using the
QIAamp RNeasy Mini Kit (Qiagen, Manchester, UK) according to the
manufacturer’s instructions. Isolated RNA was quantified using a
NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies,
Wilmington, NJ). For real-time quantitative reverse transcription
PCR, Inventoried TaqMan Gene expression Assays were used for
a-SMA (Hs00426835-g1), COL1 (Hs00164004-m1), N-cadherin
(Hs00362037-m1), OB-cadherin (Hs00901475-m1), and Cx43
(Hs00748445-s1) (Applied Biosystems, Paisley, UK) with Reverse
Transcriptase qPCR Mastermix No ROX (Eurogentec, Seraing,
Belgium). Samples were run on the ABI 7900HT Fast Real-Time
PCR System (Applied Biosystems). Expression was normalized to
GAPDH (Hs02758991-g1) (Applied Biosystems) and compared with
the level of gene expression in either baseline-respective cell types or
with the level of gene expression in HDFs, which were assigned the
value of 1 using delta CT analysis performed with the SDS software
(Applied Biosystems). Data are shown as the mean±SEM from nX3
patients (each assay was performed in triplicate).
Western blots
Cells were cultured in monolayer and treated with either N- or
OB-cadherin peptide blockers, gadolinium, or carbenoxolone for
24 hours before protein extraction. Cell lysates were prepared in lysis
buffer (25 mM HEPES (pH 7.0), 150 mM NaCl, and 1% Nonidet
P-40), containing protease inhibitor cocktail (Roche Biochemicals,
West Sussex, UK) and then electrophoresed on 10% SDS polyacry-
lamide gels (Life Technologies, Paisley, UK), followed by electro-
transfer of proteins onto PVDF transfer membranes (Perkin Elmer Life
Sciences, Cambridge, UK). Membranes were blocked in 5% BSA/Tris-
buffered salineþ 0.05% Tween and incubated overnight at 4 1C with
primary antibodies against a-SMA primary, anti-N-cadherin (Sigma),
anti-OB-cadherin (Mubio), Cx43, or vimentin (Abcam, Cambridge,
UK). Horseradish peroxidase–conjugated anti-mouse IgG (Dako,
Cambridge, UK) or anti-rabbit IgG (Amersham Biosciences, Amer-
sham, UK) were used as secondary antibodies. Bound antibody was
detected using the enhanced chemiluminescence kit and visualized
using Hyperfilm MP (Amersham Biosciences). Protein expression
was assessed using vimentin as a loading control. Semiquantitative
analysis of protein expression was performed using densitometry
analysis software (Phoretics International, Manchester, UK). Gels
shown are representative of three patients.
Small interfering RNA
Cells were seeded in six-well plates at a density of 200,000 cells per
well and cultured with DMEM, 10% FBS, and 1% penicillin–
streptomycin for 16 hours. Cells were then washed in phosphate-
buffered saline and transfected with 90 pmol siRNA and Lipofecta-
mine (both Invitrogen) according to the manufacturer’s protocol.
The assay was carried out with siRNA complexes diluted in optiMEM
(Invitrogen) with 2% FBS. Inventoried silencer-select reagents and
respective nontargeting negative controls were used for N-cadherin
(Hs464829), OB-cadherin (Hs116471), and Cx43 (Hs.368353)
(Applied Biosystems). siRNA for mechanosensitive junctions is not
available. Negative control siRNAs 1 and 2 (Applied Biosystems)
were used with sequences that do not target any gene product, and
provide a baseline to compare siRNA-treated samples. After 24 hours
of incubation, the transfection medium was replaced by DMEM,
10% FBS, and 1% penicillin–streptomycin, and the cells were
incubated for a further 24 hours. PCR and western blot analysis were
used to quantify knockdown of gene and protein expression, and
these cells were also used for experiments in the CFM. Data are
shown as the mean±SEM from nX3 patients, with each assay was
performed in triplicate.
Immunofluoresence
Cells were cultured in monolayer or 3D collagen matrices with
DMEM, 10% FBS, and 1% penicillin–streptomycin for 24 hours and
then fixed for 10 minutes with 3% paraformaldehyde in phosphate-
buffered saline and permeabilized with 0.2% Triton X-100 (Sigma).
Cells were stained with either a rabbit monoclonal anti-b-catenin or a
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rabbit polyclonal anti-Cx43 (Abcam), followed by Alexa Fluor
568–conjugated goat anti-rabbit antibody (Invitrogen), Alexa Fluor
488 Phalloidin (Invitrogen), and DNA with 406-diamidino-2-pheny-
lindole (Sigma). Secondary antibody alone was used as an immuno-
labeling control. Images were acquired using confocal microscopy
oil-immersion objectives ( 60), and the signal was analyzed by
Ultraview confocal microscopy (Perkin Elmer, Waltham, MA). The
compact configuration of MFs and HDFs in 3D collagen lattices
meant that we were unable to reliably assess Cx43 labeling under
these conditions, and therefore staining for Cx43 was performed in
monolayer cultures. Cell viability was assessed using a Live/Dead
Viability/Cytotoxicity Kit (Invitrogen). Immunofluoresence images
shown are representative of cells from five patients.
Statistics
The rate of MF- or HDF-populated collagen lattice contraction
(dynes per hour) was calculated by measuring the average gradient
of the curve between 20 and 24 hours. One-way analysis of variance
using Bonferroni’s multiple comparison test was used for comparing
all conditions. All statistical analyses were performed using software
(GraphPad Software version 5.0c, San Diego, CA). Significance was
achieved if Po0.05.
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